Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure

整合素和小窝蛋白在心脏肥大和衰竭中的作用

基本信息

  • 批准号:
    8535411
  • 负责人:
  • 金额:
    $ 63.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-09-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The mechanisms by which the cardiac myocyte (CM) senses mechanical changes and converts it to biochemical and functional effects, are poorly understood. Two areas within the CM that appear critical for proper mechanotransduction are the costamere with its resident integrins (ITGs), and caveolae, flask-shaped membrane invaginations with associated Caveolin (Cav) proteins. We and others have begun to show the importance of CM ITGs and Cav proteins in transducing mechanical signals, and that reduced expression and/ or mutation of ITGs and Cav3 can cause cardiomyopathies. How ¿1 ITGs and Cav-3 functionally interact and by what mechanisms their coordinated responses transduce mechanical signals in the CM are unknown. We have generated ¿1 ITG CM-specific knockout (KO) (termed ¿1cKO), Cav-3KO and CM-specific ITG and Cav-3 transgenic (Tg) mouse models. Our preliminary data shows that ¿1 ITG and Cav-3 co-localize and co-immunoprecipitate in the adult CM and that increased expression of ITGs and Cav-3 proteins in CMs can both preserve myocardial function when the heart is challenged with an increased mechanical load. Based on this data, we formulated our overall hypotheses that: A) ¿1 ITGs and Cav-3 have cooperative properties in organization of proteins required for CM mechanotransduction and B) that increased expression of both of these proteins in the CM will protect the heart challenged with an increased hemodynamic load from HF. We will pursue this with 3 aims using loss and gain of function approaches: 1) Determine roles of ¿1 ITGs and caveolin-3 in mechanotransductive responses of the myocardium by use of Cav3 null and ¿1 ITG cardiac myocyte specific knockout mice alone, or in combination. We will evaluate how acute and chronic mechanically mediated signals are altered when ITGs, Cav-3 or both proteins are lost from the CM and how loss of these proteins modifies the remodeling process as the heart hypertrophies and evolves towards a HF phenotype. 2) Define the interactions which direct cooperative mechanical signaling of cardiomyocyte ¿1 ITG and Cav-3. Direct interactions between ITGs and Cav3, with costameric and cytoskeletal proteins will be assessed. Proteomics will then identify novel proteins which interact with ITGs or Cav3, and how proteins in the caveolar and non-caveolar biochemical fraction of the CM change with hemodynamic challenge. 3) Determine how Tg overexpression of Cav-3 and/ or ¿¿1 ITGs alters mechanical responses, and delays or protects the heart from cardiac failure in the face of hypertrophic induction. This will allow us to directl test the potential therapeutic roles of Cav3 and ¿1 ITGs in the mechanically challenged myocardium. Clinical Significance: HF of varied causes is found in a large number of patients, necessitating frequent inpatient and outpatient care. Identification of root causes of cardiac dysfunction and importantly, studies which could lead to novel therapeutics of this common disease, are essential, and will be the focus of this proposal.
描述(由申请人提供):心肌细胞(CM)感知机械变化并将其转化为生化和功能作用的机制尚不清楚。CM内的两个区域对适当的机械转导似乎至关重要,它们是具有常驻整联素(ITGs)的costamere,以及具有相关Caveolin (Cav)蛋白的瓶状膜内陷。我们和其他人已经开始证明CM ITGs和Cav蛋白在机械信号转导中的重要性,并且ITGs和Cav3的表达减少和/或突变可引起心肌病。ITGs和Cav-3如何在功能上相互作用,以及它们的协调反应通过什么机制在CM中传递机械信号尚不清楚。我们已经建立了¿1 ITG cm特异性敲除(KO)(称为¿1cKO), Cav-3KO和cm特异性ITG和Cav-3转基因(Tg)小鼠模型。我们的初步数据表明,ITG和Cav-3在成人CM中共定位和共免疫沉淀,当心脏受到机械负荷增加的挑战时,ITG和Cav-3蛋白在CM中的表达增加都可以保护心肌功能。基于这些数据,我们提出了我们的总体假设:A) ITGs和Cav-3在CM机械转导所需的蛋白质组织中具有协同特性;B) CM中这两种蛋白质的表达增加将保护心力衰竭引起的血流动力学负荷增加的心脏。我们将使用功能丧失和功能获得的方法来实现这一目标:1)通过单独或联合使用Cav3缺失和¿1 ITG心肌细胞特异性敲除小鼠,确定¿1 ITG和小室蛋白-3在心肌机械传导反应中的作用。我们将评估当ITGs、Cav-3或这两种蛋白质从CM中丢失时,急性和慢性机械介导的信号是如何改变的,以及这些蛋白质的丢失如何改变心脏肥大和向HF表型演变的重塑过程。2)明确指导心肌细胞ITG和Cav-3协同机械信号传导的相互作用。将评估ITGs和Cav3与海岸蛋白和细胞骨架蛋白之间的直接相互作用。然后,蛋白质组学将鉴定与ITGs或Cav3相互作用的新蛋白质,以及CM的空泡和非空泡生化部分中的蛋白质如何随着血流动力学挑战而变化。3)确定Cav-3和/或ITGs的Tg过表达如何改变机械反应,延迟或保护心脏免受肥厚诱导的心力衰竭。这将使我们能够直接测试Cav3和¿1 ITGs在机械损伤心肌中的潜在治疗作用。临床意义:各种原因的心衰患者较多,需要频繁的住院和门诊治疗。确定心功能障碍的根本原因,重要的是,研究可能导致这种常见疾病的新疗法,是必不可少的,这将是本提案的重点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID M ROTH其他文献

DAVID M ROTH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID M ROTH', 18)}}的其他基金

Exosomes in aging and operative hypothermic circulatory arrest
外泌体在衰老和手术低温停循环中的作用
  • 批准号:
    9766174
  • 财政年份:
    2018
  • 资助金额:
    $ 63.54万
  • 项目类别:
ShEEP Request for Vevo 3100 Imaging System
ShEEP 请求 Vevo 3100 成像系统
  • 批准号:
    9213727
  • 财政年份:
    2016
  • 资助金额:
    $ 63.54万
  • 项目类别:
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
整合素和小窝蛋白在心脏肥大和衰竭中的作用
  • 批准号:
    8726471
  • 财政年份:
    2013
  • 资助金额:
    $ 63.54万
  • 项目类别:
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
整合素和小窝蛋白在心脏肥大和衰竭中的作用
  • 批准号:
    9061810
  • 财政年份:
    2013
  • 资助金额:
    $ 63.54万
  • 项目类别:
Integrins and Caveolin Proteins in Cardiac Hypertrophy and Failure
整合素和小窝蛋白在心脏肥大和衰竭中的作用
  • 批准号:
    8842694
  • 财政年份:
    2013
  • 资助金额:
    $ 63.54万
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    8196337
  • 财政年份:
    2010
  • 资助金额:
    $ 63.54万
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    8597371
  • 财政年份:
    2010
  • 资助金额:
    $ 63.54万
  • 项目类别:
Enhancing Cardiac Protection
加强心脏保护
  • 批准号:
    9339498
  • 财政年份:
    2010
  • 资助金额:
    $ 63.54万
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    7931351
  • 财政年份:
    2010
  • 资助金额:
    $ 63.54万
  • 项目类别:
Modulation of Natriuretic Peptides via Caveolin in Hypertrophy and Heart Failure.
通过 Caveolin 对肥大和心力衰竭中利尿钠肽的调节。
  • 批准号:
    8391592
  • 财政年份:
    2010
  • 资助金额:
    $ 63.54万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 63.54万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了